1. Home
  2. CTBI vs ZYME Comparison

CTBI vs ZYME Comparison

Compare CTBI & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTBI
  • ZYME
  • Stock Information
  • Founded
  • CTBI 1903
  • ZYME 2003
  • Country
  • CTBI United States
  • ZYME United States
  • Employees
  • CTBI N/A
  • ZYME N/A
  • Industry
  • CTBI Major Banks
  • ZYME Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTBI Finance
  • ZYME Health Care
  • Exchange
  • CTBI Nasdaq
  • ZYME Nasdaq
  • Market Cap
  • CTBI 922.9M
  • ZYME 846.1M
  • IPO Year
  • CTBI N/A
  • ZYME 2017
  • Fundamental
  • Price
  • CTBI $51.59
  • ZYME $11.32
  • Analyst Decision
  • CTBI Buy
  • ZYME Buy
  • Analyst Count
  • CTBI 2
  • ZYME 6
  • Target Price
  • CTBI $57.00
  • ZYME $19.50
  • AVG Volume (30 Days)
  • CTBI 54.5K
  • ZYME 596.8K
  • Earning Date
  • CTBI 04-16-2025
  • ZYME 05-08-2025
  • Dividend Yield
  • CTBI 3.68%
  • ZYME N/A
  • EPS Growth
  • CTBI 10.88
  • ZYME N/A
  • EPS
  • CTBI 4.79
  • ZYME N/A
  • Revenue
  • CTBI $244,136,000.00
  • ZYME $76,304,000.00
  • Revenue This Year
  • CTBI $17.58
  • ZYME $26.29
  • Revenue Next Year
  • CTBI $3.48
  • ZYME $75.78
  • P/E Ratio
  • CTBI $10.46
  • ZYME N/A
  • Revenue Growth
  • CTBI 10.52
  • ZYME 0.38
  • 52 Week Low
  • CTBI $40.19
  • ZYME $8.21
  • 52 Week High
  • CTBI $61.67
  • ZYME $17.70
  • Technical
  • Relative Strength Index (RSI)
  • CTBI 58.98
  • ZYME 41.11
  • Support Level
  • CTBI $49.00
  • ZYME $12.48
  • Resistance Level
  • CTBI $51.01
  • ZYME $13.23
  • Average True Range (ATR)
  • CTBI 1.04
  • ZYME 0.55
  • MACD
  • CTBI 0.38
  • ZYME -0.07
  • Stochastic Oscillator
  • CTBI 94.44
  • ZYME 18.55

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: